MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1
The oncoprotein transcription factor MYC is a major driver of malignancy and a highly validated but challenging target for the development of anticancer therapies. Novel strategies to inhibit MYC may come from understanding the co-factors it uses to drive pro-tumorigenic gene expression programs, pr...
Hoofdauteurs: | , , , , , , , , , , , , , |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
eLife Sciences Publications Ltd
2021-01-01
|
Reeks: | eLife |
Onderwerpen: | |
Online toegang: | https://elifesciences.org/articles/60191 |